Irene Perlich
Principal Accounting Officer, NGM Biopharmaceuticals (United States).
Companies
- NGM Biopharmaceuticals (United States)Principal Accounting Officer Sep 18, 2023 to Apr 8, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- NGM Biopharmaceuticals (United States)0 shares2Apr 5, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 5, 2024U 6,284 shares of NGM Biopharmaceuticals (United States)2
- Jan 16, 2024Shares withheld for tax 1,025 shares at $1.34 of NGM Biopharmaceuticals (United States)3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jan 18, 2024